Review: Electrolyte and antiarrhythmic drug interaction.
D000433:1-Propanol / Q000494:pharmacology; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000503:physiopathology; D001341:Autonomic Nervous System / Q000187:drug effects; D001949:Bretylium Compounds / Q000494:pharmacology; D002301:Cardiac Glycosides / Q000494:pharmacology; D004070:Digitalis / Q000494:pharmacology; D004347:Drug Interactions; D004573:Electrolytes / Q000502:physiology*; D004983:Ethanolamines / Q000494:pharmacology; D006329:Heart Conduction System / Q000187:drug effects / Q000503:physiopathology; D006801:Humans; D008012:Lidocaine / Q000494:pharmacology; D008274:Magnesium / Q000502:physiology; D008564:Membrane Potentials / Q000187:drug effects; D010672:Phenytoin / Q000494:pharmacology; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011188:Potassium / Q000037:antagonists & inhibitors / Q000502:physiology; D011342:Procainamide / Q000494:pharmacology; D011802:Quinidine / Q000494:pharmacology; D012032:Refractory Period, Electrophysiological / Q000187:drug effects; D012849:Sinoatrial Node / Q000503:physiopathology
D000889:Anti-Arrhythmia Agents; D001949:Bretylium Compounds; D002301:Cardiac Glycosides; D004573:Electrolytes; D004983:Ethanolamines; D010672:Phenytoin; D000433:1-Propanol; D008012:Lidocaine; D008274:Magnesium; D011802:Quinidine; D011342:Procainamide; D011188:Potassium